Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$3.82B |
| 2 |
Amazon
AMZN
|
$1.06B |
| 3 |
LyondellBasell Industries
LYB
|
$893M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$545M |
| 5 |
GE Aerospace
GE
|
$503M |
Top Sells
| 1 |
Cigna
CI
|
$1.26B |
| 2 |
Hewlett Packard
HPE
|
$469M |
| 3 |
GSK
GSK
|
$461M |
| 4 |
Williams Companies
WMB
|
$368M |
| 5 |
Occidental Petroleum
OXY
|
$212M |
Sector Composition
| 1 | Financials | 24.04% |
| 2 | Healthcare | 17.77% |
| 3 | Technology | 16.15% |
| 4 | Communication Services | 12.92% |
| 5 | Energy | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Chevron
CVX
$324B
| $31.7M | 0.02% | 220,508 -6,046 | -3% | -$869K |
|
102
Eli Lilly
LLY
$657B
| $22.5M | 0.02% | 69,694 -1,487 | -2% | -$481K |
|
103
AstraZeneca
AZN
$248B
| $21.2M | 0.02% | 386,365 -116,124 | -23% | -$6.37M |
|
104
Target
TGT
$43.6B
| $19.6M | 0.01% | 132,317 -1,672 | -1% | -$248K |
|
105
Travelers Companies
TRV
$61.1B
| $18.7M | 0.01% | 121,775 -3,050 | -2% | -$467K |
|
106
Fresenius Medical Care
FMS
$15.1B
| $17.9M | 0.01% | 1,275,400 | – | – |
|
107
Merck
MRK
$210B
| $16.3M | 0.01% | 189,331 -3,500 | -2% | -$301K |
|
108
Thermo Fisher Scientific
TMO
$186B
| $15.7M | 0.01% | 31,029 -575 | -2% | -$292K |
|
109
Procter & Gamble
PG
$368B
| $12.6M | 0.01% | 100,000 -650 | -0.6% | -$82.1K |
|
110
Walmart
WMT
$774B
| $11M | 0.01% | 85,190 -275 | -0.3% | -$35.7K |
|
111
Halliburton
HAL
$19.4B
| $9.39M | 0.01% | 381,301 -67,400 | -15% | -$1.66M |
|
|
HES
112
DELISTED
Hess
HES
| $9.33M | 0.01% | 85,560 -14,450 | -14% | -$1.57M |
|
113
APA Corp
APA
$8.31B
| $8.39M | 0.01% | 245,473 -44,200 | -15% | -$1.51M |
|
114
Home Depot
HD
$405B
| $8.05M | 0.01% | 29,173 -733 | -2% | -$202K |
|
115
Exxon Mobil
XOM
$487B
| $7.36M | 0.01% | 84,260 -1,176 | -1% | -$103K |
|
116
Adobe
ADBE
$151B
| $7.17M | 0.01% | 26,046 -660 | -2% | -$182K |
|
117
Pfizer
PFE
$141B
| $6.22M | ﹤0.01% | 142,186 -3,699 | -3% | -$162K |
|
118
Analog Devices
ADI
$124B
| $5.73M | ﹤0.01% | 41,141 -844 | -2% | -$118K |
|
119
Apple
AAPL
$3.45T
| $5.69M | ﹤0.01% | 41,156 | – | – |
|
120
Caterpillar
CAT
$196B
| $5.16M | ﹤0.01% | 31,437 | – | – |
|
121
Synopsys
SNPS
$112B
| $4.73M | ﹤0.01% | 15,484 | – | – |
|
122
Danaher
DHR
$147B
| $4.69M | ﹤0.01% | 18,142 | – | – |
|
123
IBM
IBM
$227B
| $4.52M | ﹤0.01% | 38,014 -900 | -2% | -$107K |
|
124
Boston Scientific
BSX
$156B
| $4.48M | ﹤0.01% | 115,590 -5,000 | -4% | -$194K |
|
125
Vulcan Materials
VMC
$38.5B
| $4.34M | ﹤0.01% | 27,500 -1,350 | -5% | -$213K |
|